BLUE KNIGHT™is a joint initiative between Johnson & Johnson Innovation –JLABS(‘JLABS’)andthe Biomedical Advanced Research and Development Authority (BARDA), a component of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services.This collaboration aims to stimulate the innovation and incubation of science and technologies that may improve health security and response by supporting companies focused on public health threats and emerging infectious diseases.

The initiative strives to create a pipeline of innovative, early-stage startups that are strategically aligned to mutual areas of interest between BARDA and the Johnson & Johnson Family of Companies, while also supporting the advancement of end-to-end, adjunct solutions with the potential to address innovation gaps along the development pathway and the continuum of care.

BLUE KNIGHT™offers physical residency at select Johnson & Johnson Innovation – JLABS (‘JLABS’) locations, as well as a virtual engagement option. Physical residency is available at:

• JLABS @ Washington, DC, the hubBlue Knightlocation with a dedicated footprint for selected companies
• Additional JLABS locations in Houston, New York City, San Diego, San Francisco, and Toronto
• JPODS and Affiliate Sites in Boston, Philadelphia and San Francisco

You may apply toBlue Knighthere

BLUE KNIGHT™offers a virtual engagement option for qualifying companies who are not location dependent and/or do not require lab space. VirtualBlue Knightcompanies may receive virtual access to the JLABS ecosystem, along with fee assistance and dedicated mentorship from the Johnson & Johnson Family of Companies and BARDA.

You may apply forBlue Knighthere

BLUE KNIGHT™residents are JLABS companies,thereforeapplicants need to meet JLABS requirements – including the requirement that eligible applicants must be an incorporated company. Incorporated companies from around the worldfocused on the development of potential vaccines, technologies and therapies dedicated to improving the speed and effectiveness of our response to existing and emerging health security threatsare eligible to apply. While individuals may not be eligible forBlue Knightresidency,all individuals are encouraged to attendBlue Knightprogramming opportunities held throughout the year.

You may apply to be considered forBLUE KNIGHT™physical residency or for virtual engagementonlinehere

BLUE KNIGHT™companies will be selected based on the following criteria:

• Compelling and credible science and/or technology that has the potential to change the trajectory of health
• Strategic alignment with the Johnson & Johnson Family of Companies' and BARDA areas of focus
• Addressing an area of significant unmet need
• Demonstrating a strong team and financial solvency

BLUE KNIGHT™opportunities are currently open to new companies seeking to join the JLABS ecosystem, current JLABS companies, and JLABS alumni

Applications are reviewed and eligible applicants will be notified on a rolling basis. Questions regarding the status of a submission may be directed to[email protected].

If your company is not selected for residency throughBLUE KNIGHT™, you may re-apply at a later date. Your company can also apply for residency at any JLABS site through the JLABS residency application.

Companies that are considering re-applying forBlue Knight居住权是强烈鼓励例证progress achieved since their last application and highlight their alignment toBlue Knight.

BLUE KNIGHT™公司将进入JLABS生态系统,including modular lab units, office space, shared core laboratory equipment and business facilities based on the availability at the location of residency, as well as intangible offerings outlined below.

Benefits unique toBlue Knightcompanies include:

• Fee assistance for certain costs associated with access to JLABS equipment and resources, which will be covered by BARDA
• Dedicated equipment forBlue Knightcompanies will be available at selectBlue Knightlocations.
• Blue Knightresidents will receive dedicated mentorship from the Johnson & Johnson Family of Companies and BARDA in mutual areas of interest.
• Throughout the year, BARDA and JLABS will co-sponsor programming customized to the needs ofBlue Knightcompanies, aligned with key areas of interest in infectious disease, public health emergency preparedness, and company acceleration.
• Blue Knightcompanies will be invited to participate in annual symposia designed to convene theBlue Knightcommunity with thought leaders, innovators and entrepreneurs.

Visithttps://jlabshub.splashthat.com/for additional information on scheduledBlue Knightprogramming across the global JLABS sites.

The infrastructure benefits and intangible offerings available to all JLABS resident companies, includingBlue Knightresidents, include:

Infrastructure:

• Flexible office workstations and office spaces
• Core research labs containing shared equipment
• Flexible, turnkey, modular dry lab and wet lab units for biology and chemistry
• Operations teams that handle the day-to-day activities (facilities, equipment, safety, operations), allowing companies to focus on the science
• Business services team to provide support as the company matures
• Global Connect: telepresence system connecting to the JLABS ecosystem and to other J&J sites of the Johnson & Johnson Family of Companies' around the world
• Year-round commercialization curriculum

Financial costs may depend on the location of residency. ForBLUE KNIGHT™companies, fee assistance for costs associated with access to JLABS equipment and resources, is covered by BARDA.

After being selected forBLUE KNIGHT™fee assistance may be provided while the company is a current JLABS resident and is strategically aligned toBlue Knight. Company alignment and eligibility may be assessed during the course of residency.

Please contact[email protected]with any questions.

The JLABS and BARDA collaboration seeks to reach the global innovation ecosystem through customized educational programming aligned with key areas of joint interest in infectious disease, public health, and company acceleration. For a full listing of JLABS global programming visithttps://jlabshub.splashthat.com.

New innovations are needed to help healthcare systems better prepare and respond to pandemics and the growing emergence of other potential global health security threats. By working in partnership with the public sector,BLUE KNIGHT™, aims to stimulate a pipeline of innovative, early-stage startups that are strategically alignedto mutual areas of interest between BARDA and Johnson & Johnson Family of Companies, while also supporting the advancement of end-to-end, adjunct solutions with the potential to address innovation gapsalong the development pathway and the continuum of care.

This joint initiative builds on established collaborations between the Johnson & Johnson Family of Companies and BARDA that aim to accelerate potential therapies and vaccines to protect communities against these threats.

Yes, companies outside the United States may be considered forBLUE KNIGHT™.

You may apply forBLUE KNIGHT™here

In August 2020, Johnson & Johnson Innovation and BARDA selected 7 companies from across the global JLABS portfolio for their promising work to fill gaps in the current set of available COVID-19 diagnostic, therapeutic, vaccine, and other technology potential solutions.

These start-up companies were the first cohort to enter theBLUE KNIGHT™collaboration, providing ‘surge force’ support in response to the COVID-19 pandemic with the aim to accelerate the development of their potential solutions to the patients, frontline healthcare workers, and communities who need them.